iSpecimen Strengthens Global Oncology Biospecimen Offering
LEXINGTON, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq:ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the addition of several new suppliers, expanded relationships with existing suppliers and new offerings to increase access to critically important biospecimens for advancing biomedical research in oncology.
Related news for (ISPC)
- Breaking News: MoBot’s Latest Update as of 09/12/25 07:00 AM
- MoBot alert highlights: NASDAQ: GCTK, NASDAQ: VSTD, NASDAQ: WTO, NASDAQ: ISPC, NASDAQ: HCWB (09/12/25 05:00 AM)
- Don’t Miss Out: MoBot’s Latest Stock Updates 09/11/25 01:00 PM
- MoBot’s Stock Market Highlights – 09/11/25 12:00 PM
- Power Hour Pulse: Biotech Surge and AI Sparks — Watch these Stocks into the Close